US FDA Approves Abbott’s Sensor-Enabled TactiCath AF Catheter

The TactiCath - Sensor Enabled contact-force ablation catheter is indicated for cardiac electrophysiological mapping and the treatment of drug refractory recurrent symptomatic paroxysmal atrial fibrillation. It adds to Abbott EnSite Precision cardiac mapping system.

MT1901_Abbott_ 712414345 _1200.jpg
• Source: shutterstock.com

More from Approvals

More from Policy & Regulation